0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sclerotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-11F4407
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Sclerotherapy Market Insights and Forecast to 2027
BUY CHAPTERS

Global Sclerotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-11F4407
Report
September 2022
111 Pages
QYResearch
Region: Global, North America, Europe, Canada, France, Germany, Italy, Turkey, Saudi Arabia, Middle East & Africa, Philippines, Malaysia, Thailand, Indonesia, Vietnam, Brazil, Argentina, Japan, South Korea, Australia, Taiwan, India
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sclerotherapy market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.

Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sclerotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Sclerotherapy.
The Sclerotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Sclerotherapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sclerotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
Product Type Insights
Global markets are presented by Sclerotherapy type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Sclerotherapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Sclerotherapy Segment by Type

Detergents
Osmotic Agents
Chemical Irritants
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Sclerotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Sclerotherapy market.

Sclerotherapy Segment by Application

Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sclerotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sclerotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Sclerotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Sclerotherapy industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sclerotherapy.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Sclerotherapy Product Introduction
1.2 Market by Type
1.2.1 Global Sclerotherapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Detergents
1.2.3 Osmotic Agents
1.2.4 Chemical Irritants
1.3 Market by Application
1.3.1 Global Sclerotherapy Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Venous Disease
1.3.3 Gastrointestinal Bleeding
1.3.4 Bronchopleural Fistula
1.3.5 Cystic Disease
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sclerotherapy Market Size Estimates and Forecasts
2.2 Sclerotherapy Market Size by Region: 2022 Versus 2028
2.2.1 Global Sclerotherapy Revenue by Region: 2017-2022
2.2.2 Global Sclerotherapy Revenue Forecast by Region (2023-2028)
2.2.3 Global Sclerotherapy Revenue Market Share by Region (2017-2028)
3 Global Sclerotherapy by Company
3.1 Global Sclerotherapy Revenue by Company (2017-2022)
3.2 Global Sclerotherapy Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Sclerotherapy Companies around the World: Ranking by Revenue
3.3.2 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Sclerotherapy Companies Headquarters & Product Type
3.4.1 Sclerotherapy Companies Headquarters
3.4.2 Global Sclerotherapy Companies Product & Service
3.4.3 Date of International Companies Enter into Sclerotherapy Market
3.5 Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 BTG
4.1.1 BTG Corporation Information
4.1.2 BTG Description, Business Overview
4.1.3 BTG Sclerotherapy Products Offered
4.1.4 BTG Sclerotherapy Revenue and Gross Margin (2017-2022)
4.1.5 BTG Sclerotherapy Revenue by Product in 2021
4.1.6 BTG Sclerotherapy Revenue by Application in 2021
4.1.7 BTG Sclerotherapy Revenue by Geographic Area in 2021
4.1.8 BTG Recent Developments
4.2 Kreussler
4.2.1 Kreussler Corporation Information
4.2.2 Kreussler Description, Business Overview
4.2.3 Kreussler Sclerotherapy Products Offered
4.2.4 Kreussler Sclerotherapy Revenue and Gross Margin (2017-2022)
4.2.5 Kreussler Sclerotherapy Revenue by Product in 2021
4.2.6 Kreussler Sclerotherapy Revenue by Application in 2021
4.2.7 Kreussler Sclerotherapy Revenue by Geographic Area in 2021
4.2.8 Kreussler Recent Developments
4.3 LGM Pharma
4.3.1 LGM Pharma Corporation Information
4.3.2 LGM Pharma Description, Business Overview
4.3.3 LGM Pharma Sclerotherapy Products Offered
4.3.4 LGM Pharma Sclerotherapy Revenue and Gross Margin (2017-2022)
4.3.5 LGM Pharma Sclerotherapy Revenue by Product in 2021
4.3.6 LGM Pharma Sclerotherapy Revenue by Application in 2021
4.3.7 LGM Pharma Sclerotherapy Revenue by Geographic Area in 2021
4.3.8 LGM Pharma Recent Developments
4.4 Troikaa
4.4.1 Troikaa Corporation Information
4.4.2 Troikaa Description, Business Overview
4.4.3 Troikaa Sclerotherapy Products Offered
4.4.4 Troikaa Sclerotherapy Revenue and Gross Margin (2017-2022)
4.4.5 Troikaa Sclerotherapy Revenue by Product in 2021
4.4.6 Troikaa Sclerotherapy Revenue by Application in 2021
4.4.7 Troikaa Sclerotherapy Revenue by Geographic Area in 2021
4.4.8 Troikaa Recent Developments
4.5 Changan Tianyu group
4.5.1 Changan Tianyu group Corporation Information
4.5.2 Changan Tianyu group Description, Business Overview
4.5.3 Changan Tianyu group Sclerotherapy Products Offered
4.5.4 Changan Tianyu group Sclerotherapy Revenue and Gross Margin (2017-2022)
4.5.5 Changan Tianyu group Sclerotherapy Revenue by Product in 2021
4.5.6 Changan Tianyu group Sclerotherapy Revenue by Application in 2021
4.5.7 Changan Tianyu group Sclerotherapy Revenue by Geographic Area in 2021
4.5.8 Changan Tianyu group Recent Developments
4.6 Bioniche Pharma Group Ltd
4.6.1 Bioniche Pharma Group Ltd Corporation Information
4.6.2 Bioniche Pharma Group Ltd Description, Business Overview
4.6.3 Bioniche Pharma Group Ltd Sclerotherapy Products Offered
4.6.4 Bioniche Pharma Group Ltd Sclerotherapy Revenue and Gross Margin (2017-2022)
4.6.5 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Product in 2021
4.6.6 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Application in 2021
4.6.7 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Geographic Area in 2021
4.6.8 Bioniche Pharma Group Ltd Recent Development
4.7 Omega Pharmaceuticals
4.7.1 Omega Pharmaceuticals Corporation Information
4.7.2 Omega Pharmaceuticals Description, Business Overview
4.7.3 Omega Pharmaceuticals Sclerotherapy Products Offered
4.7.4 Omega Pharmaceuticals Sclerotherapy Revenue and Gross Margin (2017-2022)
4.7.5 Omega Pharmaceuticals Sclerotherapy Revenue by Product in 2021
4.7.6 Omega Pharmaceuticals Sclerotherapy Revenue by Application in 2021
4.7.7 Omega Pharmaceuticals Sclerotherapy Revenue by Geographic Area in 2021
4.7.8 Omega Pharmaceuticals Recent Development
4.8 Angiodynamics
4.8.1 Angiodynamics Corporation Information
4.8.2 Angiodynamics Description, Business Overview
4.8.3 Angiodynamics Sclerotherapy Products Offered
4.8.4 Angiodynamics Sclerotherapy Revenue and Gross Margin (2017-2022)
4.8.5 Angiodynamics Sclerotherapy Revenue by Product in 2021
4.8.6 Angiodynamics Sclerotherapy Revenue by Application in 2021
4.8.7 Angiodynamics Sclerotherapy Revenue by Geographic Area in 2021
4.8.8 Angiodynamics Recent Development
4.9 ENDO-FLEX
4.9.1 ENDO-FLEX Corporation Information
4.9.2 ENDO-FLEX Description, Business Overview
4.9.3 ENDO-FLEX Sclerotherapy Products Offered
4.9.4 ENDO-FLEX Sclerotherapy Revenue and Gross Margin (2017-2022)
4.9.5 ENDO-FLEX Sclerotherapy Revenue by Product in 2021
4.9.6 ENDO-FLEX Sclerotherapy Revenue by Application in 2021
4.9.7 ENDO-FLEX Sclerotherapy Revenue by Geographic Area in 2021
4.9.8 ENDO-FLEX Recent Development
4.10 MTW ENDOSKOPIE
4.10.1 MTW ENDOSKOPIE Corporation Information
4.10.2 MTW ENDOSKOPIE Description, Business Overview
4.10.3 MTW ENDOSKOPIE Sclerotherapy Products Offered
4.10.4 MTW ENDOSKOPIE Sclerotherapy Revenue and Gross Margin (2017-2022)
4.10.5 MTW ENDOSKOPIE Sclerotherapy Revenue by Product in 2021
4.10.6 MTW ENDOSKOPIE Sclerotherapy Revenue by Application in 2021
4.10.7 MTW ENDOSKOPIE Sclerotherapy Revenue by Geographic Area in 2021
4.10.8 MTW ENDOSKOPIE Recent Development
4.11 Cook Medical
4.11.1 Cook Medical Corporation Information
4.11.2 Cook Medical Description, Business Overview
4.11.3 Cook Medical Sclerotherapy Products Offered
4.11.4 Cook Medical Sclerotherapy Revenue and Gross Margin (2017-2022)
4.11.5 Cook Medical Sclerotherapy Revenue by Product in 2021
4.11.6 Cook Medical Sclerotherapy Revenue by Application in 2021
4.11.7 Cook Medical Sclerotherapy Revenue by Geographic Area in 2021
4.11.8 Cook Medical Recent Development
5 Breakdown Data by Type
5.1 Global Sclerotherapy Revenue by Type (2017-2022)
5.2 Global Sclerotherapy Revenue Forecast by Type (2023-2028)
5.3 Sclerotherapy Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Sclerotherapy Revenue by Application (2017-2022)
6.2 Global Sclerotherapy Revenue Forecast by Application (2023-2028)
6.3 Sclerotherapy Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Sclerotherapy Market Size YoY Growth 2017-2028
7.2 North America Sclerotherapy Market Facts & Figures by Country (2017-2028)
7.3 North America Sclerotherapy Revenue by Type (2017-2022)
7.4 North America Sclerotherapy Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Sclerotherapy Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Sclerotherapy Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Sclerotherapy Revenue by Type (2017-2022)
8.4 Asia-Pacific Sclerotherapy Revenue by Application (2017-2022)
9 Europe
9.1 Europe Sclerotherapy Market Size YoY Growth 2017-2028
9.2 Europe Sclerotherapy Market Facts & Figures by Country (2017-2028)
9.3 Europe Sclerotherapy Revenue by Type (2017-2022)
9.4 Europe Sclerotherapy Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Sclerotherapy Market Size YoY Growth 2017-2028
10.2 Latin America Sclerotherapy Market Facts & Figures by Country (2017-2028)
10.3 Latin America Sclerotherapy Revenue by Type (2017-2022)
10.4 Latin America Sclerotherapy Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Sclerotherapy Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Sclerotherapy Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Sclerotherapy Revenue by Type (2017-2022)
11.4 Middle East and Africa Sclerotherapy Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Sclerotherapy Supply Chain Analysis
12.2 Sclerotherapy Key Raw Materials and Upstream Suppliers
12.3 Sclerotherapy Clients Analysis
12.4 Sclerotherapy Sales Channel and Sales Model Analysis
12.4.1 Sclerotherapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Sclerotherapy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Sclerotherapy Distributors
13 Market Dynamics
13.1 Sclerotherapy Industry Trends
13.2 Sclerotherapy Market Drivers
13.3 Sclerotherapy Market Challenges
13.4 Sclerotherapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Sclerotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Detergents
    Table 3. Major Companies of Osmotic Agents
    Table 4. Major Companies of Chemical Irritants
    Table 5. Global Sclerotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Sclerotherapy Market Size by Region (US$ Million): 2022 VS 2028
    Table 7. Global Sclerotherapy Revenue by Region (2017-2022) & (US$ Million)
    Table 8. Global Sclerotherapy Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 9. Sclerotherapy Revenue by Company (2017-2022) & (US$ Million)
    Table 10. Sclerotherapy Revenue Share by Company (2017-2022)
    Table 11. Ranking of Global Top Sclerotherapy Players by Revenue (US$ Million) in 2021
    Table 12. Global Sclerotherapy Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 13. Global Sclerotherapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sclerotherapy as of 2021)
    Table 14. Global Sclerotherapy Companies Headquarters
    Table 15. Global Sclerotherapy Companies Product & Service
    Table 16. Date of International Companies Enter into Sclerotherapy Market
    Table 17. Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
    Table 18. BTG Corporation Information
    Table 19. BTG Description and Business Overview
    Table 20. BTG Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 21. BTG Sclerotherapy Product
    Table 22. BTG Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 23. BTG Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 24. BTG Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 25. BTG Recent Development
    Table 26. Kreussler Corporation Information
    Table 27. Kreussler Description and Business Overview
    Table 28. Kreussler Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 29. Kreussler Sclerotherapy Product
    Table 30. Kreussler Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 31. Kreussler Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 32. Kreussler Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 33. Kreussler Recent Development
    Table 34. LGM Pharma Corporation Information
    Table 35. LGM Pharma Description and Business Overview
    Table 36. LGM Pharma Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 37. LGM Pharma Sclerotherapy Product
    Table 38. LGM Pharma Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 39. LGM Pharma Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 40. LGM Pharma Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 41. LGM Pharma Recent Development
    Table 42. Troikaa Corporation Information
    Table 43. Troikaa Description and Business Overview
    Table 44. Troikaa Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 45. Troikaa Sclerotherapy Product
    Table 46. Troikaa Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 47. Troikaa Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 48. Troikaa Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 49. Troikaa Recent Development
    Table 50. Changan Tianyu group Corporation Information
    Table 51. Changan Tianyu group Description and Business Overview
    Table 52. Changan Tianyu group Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 53. Changan Tianyu group Sclerotherapy Product
    Table 54. Changan Tianyu group Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 55. Changan Tianyu group Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 56. Changan Tianyu group Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 57. Changan Tianyu group Recent Development
    Table 58. Bioniche Pharma Group Ltd Corporation Information
    Table 59. Bioniche Pharma Group Ltd Description and Business Overview
    Table 60. Bioniche Pharma Group Ltd Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 61. Bioniche Pharma Group Ltd Sclerotherapy Product
    Table 62. Bioniche Pharma Group Ltd Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 63. Bioniche Pharma Group Ltd Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 64. Bioniche Pharma Group Ltd Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 65. Omega Pharmaceuticals Corporation Information
    Table 66. Omega Pharmaceuticals Description and Business Overview
    Table 67. Omega Pharmaceuticals Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 68. Omega Pharmaceuticals Sclerotherapy Product
    Table 69. Omega Pharmaceuticals Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 70. Omega Pharmaceuticals Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 71. Omega Pharmaceuticals Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 72. Angiodynamics Corporation Information
    Table 73. Angiodynamics Description and Business Overview
    Table 74. Angiodynamics Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 75. Angiodynamics Sclerotherapy Product
    Table 76. Angiodynamics Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 77. Angiodynamics Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 78. Angiodynamics Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 79. ENDO-FLEX Corporation Information
    Table 80. ENDO-FLEX Description and Business Overview
    Table 81. ENDO-FLEX Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 82. ENDO-FLEX Sclerotherapy Product
    Table 83. ENDO-FLEX Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 84. ENDO-FLEX Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 85. ENDO-FLEX Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 86. MTW ENDOSKOPIE Corporation Information
    Table 87. MTW ENDOSKOPIE Description and Business Overview
    Table 88. MTW ENDOSKOPIE Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 89. MTW ENDOSKOPIE Sclerotherapy Product
    Table 90. MTW ENDOSKOPIE Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 91. MTW ENDOSKOPIE Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 92. MTW ENDOSKOPIE Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 93. Cook Medical Corporation Information
    Table 94. Cook Medical Description and Business Overview
    Table 95. Cook Medical Sclerotherapy Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 96. Cook Medical Sclerotherapy Product
    Table 97. Cook Medical Sclerotherapy Revenue Proportion of Sclerotherapy by Product in 2021
    Table 98. Cook Medical Sclerotherapy Revenue Proportion of Sclerotherapy by Application in 2021
    Table 99. Cook Medical Sclerotherapy Revenue Proportion of Sclerotherapy by Geographic Area in 2021
    Table 100. Global Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Global Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Global Sclerotherapy Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 103. North America Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 104. North America Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 105. North America Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 106. North America Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Asia-Pacific Sclerotherapy Revenue by Region (2017-2028) & (US$ Million)
    Table 108. Asia-Pacific Sclerotherapy Revenue by Region (2023-2028) & (US$ Million)
    Table 109. Asia-Pacific Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 110. Asia-Pacific Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 111. Europe Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 112. Europe Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 113. Europe Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 114. Europe Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 115. Latin America Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 116. Latin America Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 117. Latin America Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 118. Latin America Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 119. Middle East and Africa Sclerotherapy Revenue by Country (2017-2022) & (US$ Million)
    Table 120. Middle East and Africa Sclerotherapy Revenue by Country (2023-2028) & (US$ Million)
    Table 121. Middle East and Africa Sclerotherapy Revenue by Type (2017-2022) & (US$ Million)
    Table 122. Middle East and Africa Sclerotherapy Revenue by Application (2017-2022) & (US$ Million)
    Table 123. Sclerotherapy Key Raw Materials, Industry Status and Trend
    Table 124. Sclerotherapy Key Raw Materials and Upstream Suppliers
    Table 125. Sclerotherapy Clients Status and Trend
    Table 126. Sclerotherapy Typical Clients
    Table 127. Sclerotherapy Distributors
    Table 128. Sclerotherapy Market Trends
    Table 129. Sclerotherapy Market Drivers
    Table 130. Sclerotherapy Market Challenges
    Table 131. Sclerotherapy Market Restraints
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sclerotherapy Product Picture
    Figure 2. Global Sclerotherapy Revenue Market Share by Type in 2021 & 2028
    Figure 3. Detergents Product Picture
    Figure 4. Osmotic Agents Product Picture
    Figure 5. Chemical Irritants Product Picture
    Figure 6. Global Sclerotherapy Revenue Market Share by Application in 2021 & 2028
    Figure 7. Venous Disease
    Figure 8. Gastrointestinal Bleeding
    Figure 9. Bronchopleural Fistula
    Figure 10. Cystic Disease
    Figure 11. Sclerotherapy Report Years Considered
    Figure 12. Global Sclerotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Sclerotherapy Market Size 2017-2028 (US$ Million)
    Figure 14. Global Sclerotherapy Market Size Market Share by Region: 2022 Versus 2028
    Figure 15. Global Sclerotherapy Revenue Market Share by Region (2017-2028)
    Figure 16. Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Sclerotherapy Revenue Market Share Forecast by Type (2017-2028)
    Figure 18. Global Sclerotherapy Revenue Market Share Forecast by Application (2017-2028)
    Figure 19. North America Sclerotherapy Revenue 2017-2028 (US$ Million)
    Figure 20. North America Sclerotherapy Revenue Market Share by Type (2017-2022)
    Figure 21. North America Sclerotherapy Revenue Market Share by Application (2017-2022)
    Figure 22. Asia-Pacific Sclerotherapy Revenue 2017-2028 (US$ Million)
    Figure 23. Asia-Pacific Sclerotherapy Revenue Market Share by Region (2017-2028)
    Figure 24. Asia-Pacific Sclerotherapy Revenue Market Share by Type (2017-2022)
    Figure 25. Asia-Pacific Sclerotherapy Revenue Market Share by Application (2017-2022)
    Figure 26. Europe Sclerotherapy Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 27. Europe Sclerotherapy Revenue Market Share by Country (2017-2028)
    Figure 28. Europe Sclerotherapy Revenue Market Share by Type (2017-2022)
    Figure 29. Europe Sclerotherapy Revenue Market Share by Application (2017-2022)
    Figure 30. Latin America Sclerotherapy Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 31. Latin America Sclerotherapy Revenue Market Share by Country (2017-2022)
    Figure 32. Latin America Sclerotherapy Revenue Market Share by Type (2017-2022)
    Figure 33. Latin America Sclerotherapy Revenue Market Share by Application (2017-2022)
    Figure 34. Middle East and Africa Sclerotherapy Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 35. Middle East and Africa Sclerotherapy Revenue Market Share by Country (2017-2028)
    Figure 36. Middle East and Africa Sclerotherapy Revenue Market Share by Type (2017-2022)
    Figure 37. Middle East and Africa Sclerotherapy Revenue Market Share by Application (2017-2022)
    Figure 38. Sclerotherapy Supply Chain (Upstream and Downstream Market)
    Figure 39. Global Production Market Share of Sclerotherapy Raw Materials by Region in 2021
    Figure 40. Sclerotherapy Distribution Channels
    Figure 41. Global Sclerotherapy Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 42. Global Sclerotherapy Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India
SIMILAR REPORTS